Medical Devices Market Research Reports & Consulting

Market Reports

• EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023

  The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%. The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems. The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).

  • Published: May 2018
  • Price: $ 5650
  • TOC Available:

• Sternal Closure Systems Market by Product (Closure Devices (Wire, Plate, Screw, Cable,), Bone Cement), Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy), Material (Stainless Steel, Peek, Titanium) - Global Forecast to 2023

  The global sternal closure systems market is projected to reach USD 2.61 Billion by 2023 from USD 2.02 Billion in 2018, at a CAGR of 5.2% during the forecast period. Growing availability of medical reimbursements across major markets, technological advancements in sternotomy techniques, and increased target patient population with the subsequent increase in the number of surgical procedures are expected to drive the demand for sternal closure systems during the study period. As of 2017, the major players in the sternal closure systems market are DePuy Synthes (US), Zimmer Biomet Holdings (US), and A&E Medical (US). Other players in this market include KLS Martin Group (US), Orthofix International N.V. (US), ABYRX (US), Acute Innovations (US), Kinamed Incorporated (US), Praesidia Srl (Italy), and IDEAR S.R.L. (Argentina) among others.

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023

  The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care costs may be a key restraining factor for the market in the next five years. The prominent players in the veterinary pain management market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022

  Angiographic catheters market is expected to reach USD 1,402.8 million by 2022 from USD 922.1 million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Increasing number of Cath labs in APAC, incidences of CVDs and preference for minimally invasive surgeries are few of the reasons for the growth of this market

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Magnetic Resonance Imaging Systems Market by Architecture (Open MRI Systems and Closed MRI Systems (Standard Bore and Wide Bore)), Field Strength (Low-to-mid Field, High-field (1.5T and 3T), and Very-high Field) - Global Forecast to 2023

  The global MRI systems market is projected to reach USD 7.09 Billion by 2023 from USD 5.85 Billion in 2018, at a CAGR of 3.9%. Some key factors driving market growth include the increasing geriatric population, rising awareness about the benefits of early diagnosis, and the introduction of technologically advanced MRI systems with better image quality and high throughput. Factors such as novel application areas such as detection of metastasis in cancer, hybrid MRI systems and emerging markets are expected to offer lucrative growth opportunities for players in the MRI systems market. The major players in the global MRI systems market are Siemens Healthineers (Germany), GE Healthcare (US), Phillips (Netherlands), Hitachi (Japan), and Canon Medical Systems (Japan).

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023

  The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US).

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Surgical Drapes and Gowns Market by Type (Drapes (Cardiovascular, General Surgery, C- Section, Lithotomy, Laparoscopy, Ophthalmic), Gown (Standard, Reinforced, High-Performance)), Utility (Reusable, Disposable), End User (Hospital) - Global Forecast to 2023

  The global surgical drapes and gowns market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%. Major industry players launched innovative products to maintain and improve their position in the surgical drapes and gowns market. Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Halyard Health (US), Thermo Fisher Scientific Inc. (US), Steris plc (US), and Paul Hartmann AG (Germany) have been identified as the key players in this market.

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North America, Europe, Asia) - Global Forecast to 2022

  The global neuroendoscopy devices market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1% during the forecast period. Factors such favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. The report segments the global neuroendoscopy devices market into product, application, usability, and region. The neuroendoscopy devices market includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US).

  • Published: April 2018
  • Price: $ 5650
  • TOC Available:

• Dental Implants and Prosthesis Market by Type (Dental Implants, Bridge, Crown, Abutment, Dentures, Veneers, Inlay & Onlays), Material (Titanium, Zirconium, Metal, Ceramic, Porcelain Fused To Metal), Type of Facility - Global Forecast to 2023

  The global market is projected to reach USD 13.01 billion by 2023 from USD 9.50 billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related dental diseases, rising prevalence of tooth decay and periodontal diseases in the overall population across the globe, increasing willingness to adopt dental cosmetic surgery, and the growing number of implant placing dentists. However, the high cost of premium dental implants and limited reimbursement, and high risk of tooth loss associated with dental bridges may expect to hinder the growth of this market during the forecast period. The dental implants and prosthesis market is fragmented market; and some of the major players competing in this market are Institut Straumann AG (Switzerland), DENTSPLY Sirona Inc. (US), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), AVINENT Implant System (Spain), Henry Schein, Inc. (US), OSSTEM Implant Co., Ltd. (South Korea), DIO Corporation (South Korea), Merz Dental GmbH (Germany), Bicon, LLC (US), Shofu Dental Corporation (Japan), Thommen Medical AG (Switzerland), and Southern Implant (South Africa).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Urgent Care Center Market by Service (Acute Illness Treatment, Trauma/Injury Treatment, Physical Examination, Immunization & Vaccination), Ownership (Corporate Owned, Physician Owned, Hospital Owned), and Region - Global Forecast to 2023

  The global urgent care center market is projected to reach USD 25.93 Billion by 2023 from USD 20.07 Billion in 2018, at a CAGR of 5.3% during the forecast period. The growth of this market is driven by factors such as growing investments in urgent care, increasing geriatric population, strategic developments between urgent care providers and hospitals, and affordable care and shorter waiting periods offered by urgent care centers. Concentra (US), MedExpress (US), American Family Care (US), NextCare Holdings (US), and FastMed Urgent Care (US) are the key players in the urgent care center market. Other players involved in this market are CityMD (US), CareNow Urgent Care (US), GoHealth Urgent Care (US), HCA Healthcare UK (UK), Columbia Asia Hospitals (India), International SOS (China), and St. Joseph's Health Care London (Canada).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Medical Display Market by Technology (LED, OLED) Panel Size (≤22.9”, 27.0-41.9”, ≥42”) Resolution (≤2MP, 4.1-8MP, ≥8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display color - Global Forecast to 2023

  The global medical display market is projected to reach USD 2.33 Billion by 2023 from USD 1.86 Billion in 2018, at a CAGR of 4.6%. Growing adoption of hybrid ORs, short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of Diagnostic Imaging centers are the major factors driving the growth of the market. However, market saturation and the increased adoption of refurbished medical displays are expected to restrain the growth of this market to a certain extent. Prominent players in the healthcare medical display market include Barco (Belgium), EIZO (Japan), Sony (Japan), LG Display (South Korea), Novanta (US), FSN Medical (South Korea), Advantech (Taiwan), Quest International (US), STERIS (UK), Jusha Medical (China), Double Black Imaging (US), Dell (US), HP (US), Shenzhen Beacon Display (China), COJE Display (South Korea), and Axiomtek (Taiwan).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Automated blood Tube Labeler & Specimen Transport Box Market – By End User (Hospitals, Diagnostic Center, Skilled Nursing Facility, Long Term Acute Care Facilities), Specimen Transport Box Type (Traditional Boxes, Smart Transportation Boxes) - Forecast to 2022

  The automated blood tube labeler market is expected to reach USD 142.0 Million by 2022 from USD 102.3 Million in 2017, at a CAGR of 6.8% during the forecast period. The scope of the report includes automated tube labeler used to label blood tubes. The specimen transportation box market is expected to reach USD 135.8 Million by 2022 from USD 94.7 Million in 2017, at a CAGR of 7.5% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The automated tube labeler market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022

  The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecast to 2023

  The global colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Cranial Fixation & Stabilization Systems Market by Product (Screw, Mesh, Skullclamp, Horseshoe Headrest, Accessories, Adaptor, Arms, Base units), Material (Nonresorbable, Resorbable), End User (Hospitals, ASC), and Region - Global Forecast to 2022

  The global cranial fixation and stabilization systems market is expected to reach USD 1.74 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 8.7%. The growth of this market is mainly driven by the increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries. The cranial fixation and stabilization systems market is highly competitive with the presence of several large as well as emerging players. Prominent players in the cranial fixation and stabilization systems market include B. Braun (Germany), Changzhou Huida (China), DePuy Synthes (US), Evonos (Germany), Integra (US), Jeil Medical (South Korea), KLS Martin (Germany), Medicon (Germany), Medtronic (Ireland), Micromar (Brazil), NEOS Surgery (Spain), OsteoMed (US), Pro Med Instruments (Germany), Stryker (US), and Zimmer Biomet (US).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022

  The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).

  • Published: March 2018
  • Price: $ 5650
  • TOC Available:

• Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022

  The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), F. Hoffman-la Roche (Switzerland), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).

  • Published: February 2018
  • Price: $ 5650
  • TOC Available:

• Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Management), Application (Knee, Hip, Shoulder), End User (Hospitals, Ambulatory Surgery Centers & Clinics) - Global Forecast to 2022

  The global arthroscopy instruments market is projected to reach USD 5.61 Billion by 2022 from USD 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period. The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. The major players of the arthroscopy instruments market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India).

  • Published: February 2018
  • Price: $ 5650
  • TOC Available:

• Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023

  The global embolic protection devices market is projected to reach USD 604.9 Million by 2023 from USD 405.5 Million in 2018, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period. The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

  • Published: February 2018
  • Price: $ 5650
  • TOC Available:

• RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) - Global Forecast to 2022

  The global RSV diagnostics market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

  • Published: February 2018
  • Price: $ 5650
  • TOC Available:

• Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022

  The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).

  • Published: February 2018
  • Price: $ 5650
  • TOC Available:

• Intraocular Lens Market by Type (Traditional/Monofocal (Spheric, Aspheric), Premium (Multifocal, Accommodating, and Extended Depth of Focus), and Phakic), Material (PMMA, Foldable), End User (Hospital, Clinic), and Region - Global Forecast to 2022

  The global Intraocular Lens Market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly driven by the growth in the geriatric population and corresponding age-related eye disorders, rising prevalence of eye diseases & diabetes in the overall population across the globe, and increasing government initiatives to control and treat blindness caused by cataract. The key players in the global intraocular lenses market are Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Oculentis GmbH (Germany), NIDEK CO., LTD. (Japan), Aurolab (India), Omni Lens Pvt Ltd. (India), Care Group (India), Hanita Lenses R.C.A Ltd. (Israel), and Fred Hollows Intraocular Laboratory (Eritrea).

  • Published: January 2018
  • Price: $ 5650
  • TOC Available:

• Bone Cement & Glue Market by Type (PMMA, Calcium Phosphate, Natural, Synthetic), Application (Arthroplasty (Total Knee, Hip, Shoulder), Kyphoplasty, Vertebroplasty), End User (Hospitals, Clinics, Ambulatory Surgery Centers) - Global Forecast to 2022

  The global bone cement and glue market is expected to reach USD 1,322.6 Million by 2022 from USD 993.0 Million in 2017, at a CAGR of 5.9%. The market growth is primarily driven by the growing incidence of sports injuries and increasing developments in Regenerative Medicine field. Key players in the bone cement and glue market include Stryker (US), Zimmer Biomet (US), DePuy Synthes (US), Smith & Nephew (UK), Arthrex (US), DJO Global (US), Exactech (US), TEKNIMED (France), Heraeus Medical (Germany), CryoLife (US), Cardinal Health (US), and Trimph (Australia).

  • Published: January 2018
  • Price: $ 5650
  • TOC Available:

• Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

  The global vascular grafts market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).

  • Published: January 2018
  • Price: $ 5650
  • TOC Available:

• Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022

  Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The global neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US).

  • Published: January 2018
  • Price: $ 5650
  • TOC Available:

• Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022

  The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).

  • Published: January 2018
  • Price: $ 5650
  • TOC Available:

• Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022

  The global market for clinical laboratory services is projected to reach $146.41 billion by 2022 from $113.44 billion in 2017, at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022

  The global amniocentesis Needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis Needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market.

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022

  The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022

  The global blood glucose monitoring system market was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the blood glucose monitoring system market. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• Optometry/Eye Exam Equipment Market by Type (OCT, Fundus Cameras, Perimeters, Ophthalmoscope, Ultrasound, Autorefractor, Slit Lamp, Corneal Topography, Lensmeter, Chart Projectors, Wavefront Analyzer), End User (Hospital, Clinic) - Global Forecast to 2022

  The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0% during the forecast period. Growth in this market can primarily be attributed to the rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes. The prominent players in the global eye exam equipment market are Carl Ziess (Germany), Haag-Streit (Switzerland), Topcon (Japan), NIDEK (Japan), Heidelberg Engineering (Germany), Escalon (US), Novartis (Switzerland), Valent (Canada), Canon (Japan), Essilor (France), Heine Optotechnik (Germany), and Luneau Technology (France).

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• EMS Products Market by Type (Laryngoscope, ET Tube, ECG, Pulse Oximeter, EEG, ICP, TCD, Temperature and Pre-Natal Monitors, Disinfectant, Dressing, Suture, Staple, Wheelchair, Beds), Application (Cardiac, Trauma), End User - Global Forecast to 2022

  The global emergency medical service (EMS) products market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US).

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

  A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. The gastrointestinal stents market is expected to reach USD 452.6 Million by 2022 from USD 337.5 Million in 2016, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The prominent players in the global gastrointestinal stents market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).

  • Published: December 2017
  • Price: $ 5650
  • TOC Available:

• Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022

  The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).

  • Published: November 2017
  • Price: $ 5650
  • TOC Available:

• Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) - Global Forecast to 2022

  The blood warmer devices market is expected to reach USD 225.6 Million by 2022 from USD 138.7 Million in 2016 at a CAGR of 8.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players in the Tissue Diagnostics market include 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US).

  • Published: November 2017
  • Price: $ 5650
  • TOC Available:

• Thawing System Market by Type (Manual, Automated), Sample (Blood, Plasma, RBC, Platelets, Whole Blood, Embryo, Semen), End User (Blood Bank, Transfusion Center, Hospital, Tissue Bank, Biotechnology & Pharmaceutical) - Global Forecast to 2022

  The thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes. Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).

  • Published: November 2017
  • Price: $ 5650
  • TOC Available:

• Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022

  The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market. Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

  • Published: November 2017
  • Price: $ 5650
  • TOC Available:

• Intravascular Temperature Management Market by Type (Warming, Cooling), Application (Perioperative, Post-operative, Acute Care), Medical Condition (Stroke, Cardiac Arrest, Traumatic Brain Injury (TBI), Myocardial Infarction) - Global Forecasts to 2022

  The global intravascular temperature management market is projected to reach USD 272.3 Million by 2022 from USD 219.8 Million in 2016, growing at a CAGR of 3.6%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. Key players in the intravascular temperature management market include 3M (US), Smiths (UK), ZOLL Medical (US), The 37Company (Netherlands), Belmont Instrument (US), Biegler (Austria), Stihler Electronic (Germany), and BD company (US).

  • Published: November 2017
  • Price: $ 18000
  • TOC Available:

• US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022

  The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.

  • Published: November 2017
  • Price: $ 5650
  • TOC Available:

• Weight Loss and Weight Management Market by Equipment (Surgical Equipment (Biliopancreatic Diversion, Gastric Bypass), Fitness (Treadmill, Elliptical, Stair Stepper)), Diet (Meal, Beverage, Supplement) and Weight Loss Services - Global Forecast to 2022

  The weight loss and weight management market is projected to reach USD 245.51 Billion by 2022 from USD 175.94 Billion in 2017, at a CAGR of 6.9%. Factors such as growing obesity rates, increasing number of bariatric surgeries, and increasing prevalence of lifestyle diseases are driving the global weight loss and weight management market. The weight loss and weight management market is highly competitive, with the presence of several small and large players. Some of the players operating in this market include Atkins Nutritionals (US), Herbalife (US), Nutrisystem (US), Ethicon (US), Covidien (US), Apollo Endosurgery (US), Brunswick (US), Amer Sports (Finland), Johnson Health Technology (Taiwan), Technogym (Italy), Weight Watchers (US), Jenny Craig (US), eDiets.com (US), VLCC Healthcare (India), Slimming World (UK), The Gold’s Gym (US), Duke Diet & Fitness Center (US), Equinox (US), Life Time Fitness (US), Fitness First Group (US), and Town Sports (US).

  • Published: October 2017
  • Price: $ 5650
  • TOC Available:

• Wound Drainage/Surgical Drains Market by Product (Accessories, System (Open, Closed)), Type (Active, Passive), Application (Orthopedic, CVD, Thoracic, Obstetrics & Gynecology, Plastic surgery), End user (Hospitals, Clinics, ASC) - Global Forecast to 2022

  The surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.78 Billion in 2016, growing at a CAGR of 3.7% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The surgical drains market is highly competitive with the presence of several small and big players. Some of the players in the surgical drains market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (Indiana), Global Medikit (India), and Degania Silicone (Israel).

  • Published: October 2017
  • Price: $ 5650
  • TOC Available:

• Hysteroscopy Instruments Market by Product (Forceps, Scissors, Hysteroscope (Rigid, Flexible), Resectoscope (Unipolar, Bipolar), Usability, Application (Diagnosis, Myomectomy, Polypectomy, EA), End User (Hospital, Clinic, ASC) - Global Forecast to 2022

  The hysteroscopy instruments market is expected to reach USD 1.89 Billion by 2022 from USD 1.30 Billion in 2017, at a CAGR of 7.8%. The growth of the market is attributed to the growth in female geriatric population and the rising incidence of gynecological diseases; increasing adoption of minimally invasive treatments; implementation of favorable government initiatives and the increasing adoption of office hysteroscopy. The hysteroscopy instruments market is highly competitive with the presence of several small and big players. Some of the players in the hysteroscopy instruments market include KARL STORZ (Germany), Olympus (Japan), Richard Wolf (Germany), Stryker (US), Hologic (US), Medtronic (Ireland), Ethicon (Scotland), B. Braun (Germany), Boston Scientific (US), MedGyn Products (US), CooperSurgical (US) , Cook Medical (US), Medicon (Germany), Maxer Medizintechnik (Germany), and Hospiline Equipments (India).

  • Published: October 2017
  • Price: $ 5650
  • TOC Available:

• Cancer Biomarkers Market by Type (Protein Biomarker, Genetic Biomarker), Cancer Type (Breast, Melanoma, Leukemia, Lung), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnosis, Prognostics, R&D) - Global Forecast to 2022

  Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids. They enhance cancer detection and facilitate high-speed noninvasive diagnosis using Genomics and proteomics. The global cancer biomarkers market is accounted for USD 10.31 Billion in 2016 and is expected to grow at a CAGR of 12.2% to USD 20.48 Billion by 2022 during the forecast period. The major players in the cancer biomarkers profiling technology market are Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson (US), and Hologic (US).

  • Published: October 2017
  • Price: $ 7150
  • TOC Available:

• In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022

  The global in vitro fertilization market is projected to be valued at USD 465.2 Million in 2016 and is expected to grow at a CAGR of 10.9% from 2017 to reach to USD 847.8 Million by 2022. The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the major players in the in vitro fertilization market. Other players include Esco Micro (Singapore), IVFtech (Denmark), EMD Sereno (US), Genea Limited (Australia), Rocket Medical (UK), and Nidacon International (Sweden).

  • Published: October 2017
  • Price: $ 5650
  • TOC Available:

• Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022

  The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes. The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany).

  • Published: September 2017
  • Price: $ 5650
  • TOC Available:

• Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022

  The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical.

  • Published: September 2017
  • Price: $ 5650
  • TOC Available:

• Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022

  The global liquid biopsy market is projected to be valued at USD 580.0 Million in 2016 and is expected to grow at a CAGR of 23.4% to reach to USD 2,047.9 Million by 2022. Base year considered for the report is 2016 and forecast period includes 2017–2022. Some of the key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D. The key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).

  • Published: September 2017
  • Price: $ 5650
  • TOC Available:

• Restorative Dentistry Market by Product (Restorative Material (Composite, Amalgam, Ceramic, Adhesive, Biomaterial), Prosthetic, Equipment (CAD/CAM, Handpiece, Articulator, Furnace) End User (Hospital, Dental Clinic, Laboratory) - Global Forecast to 2022

  The global restorative dentistry market is projected to reach USD 21.27 Billion by 2022 from USD 14.64 Billion in 2016, at a CAGR of 6.4% from 2017 to 2022. The major players in the restorative dentistry market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), Institut Straumann (Switzerland), 3M Company (US), Zimmer Biomet Holdings, Inc. (US), Ultradent Products, Inc. (US), GC Corporation (Japan), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), Ivoclar Vivadent AG (Liechtenstein), COLTENE Holding (Switzerland), and VOCO (Germany).

  • Published: September 2017
  • Price: $ 5650
  • TOC Available:

• Dental Lab Market by Material (Metal Ceramic, Ceramic (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, Scanner, Furnace, Articulators), Prosthetics (Bridge, Crown (Porcelain Fused to Metal, CAD CAM Ceramics), Dentures) - Global Forecast to 2022

  The global dental laboratories market is projected to reach USD 43.08 Billion by 2022 from USD 32.56 Billion in 2017, at a CAGR of 5.8% from 2017 to 2022. The major players in the dental laboratories market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), 3M Company (US), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Oy (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Zimmer Biomet Holdings, Inc. (US), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), and Shofu Inc. (Japan).

  • Published: September 2017
  • Price: $ 5650
  • TOC Available:

• Bioabsorbable Stents Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022

  The global bioresorbable stents market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022. Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth. The bioresorbable stents screening market is a niche market with the presence of several emerging players and few big players. Prominent players in the market include Abbott (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).

  • Published: August 2017
  • Price: $ 5650
  • TOC Available:

• First
• Previous
• 3
• 4
• 5
• 6
• 7
• Next
• Last